ReviewDer Urologe. Ausg. A2019

[Cochrane Rapid Review: the immune checkpoint inhibitor pembrolizumab versus chemotherapy for the treatment of advanced urothelial carcinoma].

D Wilborn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.